Blair William & Co. IL Has $2.63 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Blair William & Co. IL trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 8,750 shares of the company's stock after selling 820 shares during the period. Blair William & Co. IL's holdings in HCA Healthcare were worth $2,626,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Whipplewood Advisors LLC acquired a new position in shares of HCA Healthcare during the fourth quarter valued at about $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $36,000. Legacy Investment Solutions LLC bought a new stake in HCA Healthcare in the third quarter valued at about $39,000. Activest Wealth Management lifted its stake in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.6 %

Shares of HCA traded up $2.00 during midday trading on Thursday, hitting $349.03. The stock had a trading volume of 1,946,885 shares, compared to its average volume of 1,354,285. The company has a 50 day simple moving average of $326.35 and a two-hundred day simple moving average of $340.30. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a market cap of $85.93 billion, a price-to-earnings ratio of 15.89, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm earned $5.90 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a dividend of $0.72 per share. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. HCA Healthcare's payout ratio is 13.11%.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Bank of America dropped their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. Barclays reduced their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research report on Monday, January 27th. Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Morgan Stanley cut their price objective on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada reduced their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $385.67.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.